254 articles
The Delhi High Court’s decision in Kudos Pharma v. Natco Pharma reviews crucial aspects of patent law, including credible challenge and the distinction between patent coverage and disclosure.…
The Delhi High Court has reiterated that objections on insufficiency of disclosure in patent applications must be clear and precise. Procedural lapses by the Indian patent office can…
The Madras High Court has overturned the refusal of Microsoft’s patent application, clarifying the correct approach to assessing inventive step and the PSITA standard under Indian law. The…
The Madras High Court held that delays in filing a request for examination can be condoned under exceptional circumstances, particularly when caused by agent errors. This case highlights…
Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO's decision on double patenting, updates from…
This week’s patent news features a free masterclass on patent filing, Nokia and Daimler’s settlement of a SEP dispute, and the EU’s alternative proposal to the WTO on…
This week’s Indian patent statistics reveal a notable decline in patent publications and grants compared to the previous week. The report offers a comprehensive breakdown by city and…
Natco Pharma has withdrawn its compulsory license application for Baricitinib following an agreement with Eli Lilly. The Indian Patent Office has extended procedural deadlines, and other significant updates…
Natco seeks a compulsory license for Baricitinib, while the USA backs a temporary COVID-19 vaccine patent waiver. The EU critiques the US approach, and Ericsson and Samsung resolve…
The Supreme Court has indefinitely extended limitation periods for legal proceedings in view of the COVID-19 situation and questioned the Government's approach to compulsory licensing of essential medicines.…